Stockreport

ALK enters into neffy® co-promotion agreement in the USA [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF Agreement does not change ALK's revenue and earnings outlook for 2025. ALK (ALKB.DC / OMX: ALK B) today announced a 4-year agreement with US-based ARS Pharmaceuticals [Read more]